Markets›Health care›DHR

Danaher

DHR
224.49
+0.72 (+0.32%)
Closing price for Sep 25, 2026 from Polygon.io

Valuation

Market value157.81B
Enterprise value180.02B
Price to earnings (P/E)39.9
Price to sales6.3
Price to book3.0
Enterprise value to EBITDA30.5
Free cash flow yield3.5%

Profitability (last 12 months)

Revenue25.11B
Net income4.00B
Gross margin58.5%
Operating margin20.4%
Net margin15.9%
Return on equity7.6%
Return on assets4.3%

Growth (last fiscal year, FY 2025)

Revenue growth+2.9%
EPS growth-4.5%

Balance sheet (latest quarter)

Cash and equivalents4.35B
Total debt26.56B
Debt to equity0.51
Current ratio1.65

Per share and dividends

EPS, diluted (last 12 months)5.63
Shares outstanding702.99M
Dividends paid (last 12 months)None

Trading

Price224.49
52-week high242.80
52-week low160.93
1-year price change+20.65%
Average volume (3 months)4.65M
Beta against the S&P 500 (1 year)0.43

Calculated from Danaher's SEC filings (latest quarter ending Jun 26, 2026) and the price above. "Last 12 months" adds up the four most recent quarters. Beta compares one year of daily returns with the S&P 500 (SPY). Dividends from Polygon.io or Nasdaq.